Nomura Asset Management’s Celldex Therapeutics CLDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | – | – | 1583 |
|
|
2025
Q1 | – | Hold |
0
| – | – | – | 1599 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 1543 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 1542 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 1558 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 1567 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 1585 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 1599 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 1600 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 1591 |
|
|
2015
Q3 | – | Sell |
-15,000
| Closed | -$378K | – | 894 |
|
|
2015
Q2 | $378K | Sell |
15,000
-35,000
| -70% | -$882K | 0.01% | 836 |
|
|
2015
Q1 | $1.39M | Buy |
50,000
+20,000
| +67% | +$558K | 0.02% | 501 |
|
|
2014
Q4 | $545K | Buy |
+30,000
| New | +$545K | 0.01% | 784 |
|
|
2014
Q1 | – | Sell |
-20,000
| Closed | -$484K | – | 878 |
|
|
2013
Q4 | $484K | Sell |
20,000
-5,000
| -20% | -$121K | 0.01% | 769 |
|
|
2013
Q3 | $886K | Sell |
25,000
-5,000
| -17% | -$177K | 0.02% | 586 |
|
|
2013
Q2 | $468K | Buy |
+30,000
| New | +$468K | 0.01% | 753 |
|